Findings from Georgia State University Yields New Data on Metabolic Syndrome (Lifestyle Modification Practices and Drug Prescription Use In Elderly Americans With Metabolic Syndrome: a Nationwide Population-based Study)

2021 JAN 26 (NewsRx) -- By a News Reporter-Staff News Editor at NewsRx Drug Daily -- Fresh data on Nutritional and Metabolic Diseases and Conditions - Metabolic Syndrome are presented in a new report. According to news reporting out of Atlanta, Georgia, by NewsRx editors, research stated, “To determine differences in lifestyle modification practices and use of prescription drugs in a representative sample of Mexican American (MA) non-Hispanic White (NNW), and non-Hispanic Black (NHB) elderly Americans with metabolic syndrome (MetS). Data from the United States National Health and Nutritional Examination Surveys were used in this study.”

Our news journalists obtained a quote from the research from Georgia State University, “Lifestyle modification practices include ongoing physical activity. weight control, and ongoing diet modifications. Prescription drugs include anti-diabetic, anti-obesity, lipid-lowering, insulin sensitizers, renin-angiotensin system (RAS) blockers, fibrates, and cilostazol. Race/ethnic-specific prevalence odds ratios from the multivariate Logistic regression analyses were used to determine associations between selected independent variables and MetS control {defined as the use of lifestyle modification practices or prescription drugs), adjusting for covariates. The rates of ongoing weight control (73.4% versus 68.1% in MA and 66.3% in NHW) and diet modification practices (78.1% versus 77.4% in MA and 66.7% in NHW) were higher among NHB, and rate of ongoing physical activity (61.8% versus 52.8% in NHW and 56.4% in NHB) was higher among MA participants compared to their other racial/ethnic elderly counterparts (P <0.001). Lipid-lowering and insulin-sensitizing drugs were the most commonly used prescription drugs in the last 30 days. The prevalence of nonuse of lifestyle modification practices or prescription drugs for MetS management was 15.1%, 21.3%, and 12.7% in MA, NHW, and NHB participants, respectively. MA, NHB race/ethnicity, a higher level of education, and increased BMI were significantly associated with increased odds of MetS control. Lack of drug prescription insurance and increased age were associated with decreased odds of MetS control. Given the clinical importance of MetS, improving knowledge-based health decisions relative to lifestyle modification practices is very important.”

According to the news editors, the research concluded: “Moreover, sources of low-cost medications that links elderly patients with drug prescription coverage programs may help to improve the management of MetS.”

This research has been peer-reviewed.

For more information on this research see: Lifestyle Modification Practices and Drug Prescription Use In Elderly Americans With Metabolic Syndrome: a Nationwide Population-based Study. Journal of the National Medical Association, 2020;112(6):621-631. Journal of the National Medical Association can be contacted at: Elsevier, 1012 10TH St, N W, Washingon, DC 20001, USA.

Our news journalists report that additional information may be obtained by contacting Ike S. Okosun, Georgia State University, School of Public Health, Dept. of Population Health Sciences, Suite 461, Urban Life Bldg, Pob 3984, Atlanta, GA 30302, United States. Additional authors for this research include Stanley Nkemjika, Bryan Okosun, Rodney Lyn and Collins O. Airhihenbuwa.

The direct object identifier (DOI) for that additional information is: https://doi.org/10.1016/j.jnma.2020.06.008. This DOI is a link to an online electronic document that is either free or for purchase, and can be your direct source for a journal article and its citation.

(Our reports deliver fact-based news of research and discoveries from around the world.)